Discover trends, market shifts, and competitive outlooks for the chronic lower back pain industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Chronic Lower Back Pain Market Growth Evolved From 2024 To 2025, And What’s Ahead?

Over the years, there has been a stable rise in the market size for chronic lower back pain. The market is envisaged to surge from $7.72 billion in 2024 to reach $8.08 billion in 2025, marking a compound annual growth rate (CAGR) of 4.6%. The growth witnessed in the past years is a result of factors such as inactive living standards, manual work and job-related risks, advancements in medical field, particularly diagnosis, development in pain management strategies, and epidemiological research.

In the coming years, the market size for chronic lower back pain is projected to witness robust expansion. It’s anticipated to scale up to $9.99 billion by 2029, with a compound annual growth rate (CAGR) of 5.5%. The projected growth in this time frame can be ascribed to the increase in non-pharmacological interventions, preventive health care efforts, emphasis on all-inclusive treatments, advances in regenerative medicine, and an aging population trend. The key trends during this projection period includes an increased inclination towards non-pharmacological interventions, alterations in pain management methods, heightened awareness and education in healthcare, expansion of telemedicine and remote monitoring, and the integration of regenerative medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

What are the Fundamental Drivers and Innovations Shaping the Chronic Lower Back Pain Market?

The chronic lower back pain market’s growth is anticipated to be fueled by a rise in nerve instances. These instances denote specific scenarios where an individual exhibits courage or resilience when encountering a difficult or intimidating situation. Central sensitization, which describes a condition where the nervous system becomes overly sensitive, experiencing pain more severely even when there’s no physical injury, can emerge from constant exposure to stress and pain. For example, as per Nature, a prominent UK-international science journal, in July 2023, the prevalence of peripheral neuropathy related to nerve damage is noted to be 28.4% in adults aged 40 or above with diabetes and 11.8% in those without diabetes. Therefore, the surge in nerve instances is propelling the expansion of the chronic lower back pain market.

How Is the Chronic Lower Back Pain Market Segmented?

The chronic lower back pain market covered in this report is segmented –

1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain

2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain

3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis

2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis

3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions

4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints

5) By Radicular Pain: Sciatica, Nerve Root Compression

6) By Muscular Pain: Muscle Strain, Muscle Spasm

7) By Other Types of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9946&type=smp

Which Regions Are Driving the Next Phase of the Chronic Lower Back Pain Market Growth?

North America was the largest region in the chronic lower back pain market in 2024. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Chronic Lower Back Pain Market?

Prominent companies in the chronic lower back pain market are striving to maintain their market dominance by focusing on the creation of innovative medications. By developing new drugs, they can enhance treatment results for patients suffering from diverse health conditions. Take for instance, in July 2022, Amneal Pharmaceuticals, an American pharmaceutical enterprise, introduced LYVISPAH, a FDA approved baclofen oral granule (available in 5, 10, and 20 mg dosages), for the management of spasticity linked to multiple sclerosis and other similar spinal cord disorders. LYVISPAH effectively treats and alleviates flexor spasms, clones, muscular rigidity, and the associated pain. It gives a flexible, customized dosage through single-dose granule packages available in dosages of 5mg, 10mg, and 20mg. The medicine is bioequivalent to oral baclofen tablets, and patients with spinal cord related injuries or conditions might find LYVISPAH beneficial.

View the full report here:

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

How Is the Chronic Lower Back Pain Market Defined and What Are Its Core Parameters?

Chronic low back pain (CLBP) refers to a pain that persists for 12 weeks or more despite the treatment of the underlying cause of acute low back pain or the initial injury. Chronic low back pain is the major cause of disability and psychological issues such as stress, depression, and/or anxiety.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9946

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model